Meta-Analysis Comparing Potent Oral P2Y12 Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
Matteo CasulaFederico FortuniMarco FerliniFrancesca FabrisLuigi Oltrona ViscontiSergio LeonardiPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2021)
In patients receiving OAC therapy for AF after a recent PCI, potent oral P2Y12 inhibitors increase the risk of clinically relevant bleeding compared with clopidogrel, with no evident benefit in terms of MACE reduction.
Keyphrases
- percutaneous coronary intervention
- acute coronary syndrome
- antiplatelet therapy
- atrial fibrillation
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery disease
- systematic review
- coronary artery bypass grafting
- coronary artery bypass
- anti inflammatory
- meta analyses
- heart failure
- randomized controlled trial